Active, Not Recruiting
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer
NCT05586061
- Conditions
- HER2-positive Gastric Cancer
- Locations
-
- Central Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
- Qilu Hospital of Shandong University Jinan, Shandong, China
- Shandong Provincial Hospital Affiliated to Shandong First Medical Universiry Jinan, Shandong, China
- The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital) Jinan, Shandong, China